Acute leukaemia

• Science & Technology

Researchers uncover weakness in leukaemia cells

UK scientists have found that a pair of genes inside cells could play a major role in how a serious form of leukaemia develops. UK scientists have found that a pair of genes inside cells could play a major role in how a serious form of leukaemia develops.

11 January 2016

• Science & Technology

New leukaemia gene stops blood cells ‘growing up’

Scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients Scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients

14 September 2015

• Health & Medicine

Cure for young acute myeloid leukaemia patients increases six-fold since 1970s

Almost half of teens and young adults with acute myeloid leukaemia (AML) – a typically aggressive form of leukaemia – are cured thanks to improvements in treatment and care, according to research published in the British Journal of Haematology. Almost half of teens and young adults with acute myeloid leukaemia (AML) – a typically aggressive form of leukaemia – are cured thanks to improvements in treatment and care, according to research published in the British Journal of Haematology.

22 June 2013

• Science & Technology

US researchers unveil womb cancer and acute leukaemia genomes

US researchers have published details of the genetic makeup of two more forms of cancer - acute myeloid leukaemia (AML) and womb (endometrial) cancer. US researchers have published details of the genetic makeup of two more forms of cancer - acute myeloid leukaemia (AML) and womb (endometrial) cancer.

1 May 2013

Protein that takes care of our DNA is critical to leukaemia cell survival

A protein – already known to be involved in a cell's response to stress – called Tetratricopeptide repeat domain 5 (TTC5) is critical to the development of acute myeloid leukaemia (AML), according to a new Cancer Research UK study published in Cell Death and Disease A protein – already known to be involved in a cell's response to stress – called Tetratricopeptide repeat domain 5 (TTC5) is critical to the development of acute myeloid leukaemia (AML), according to a new Cancer Research UK study published in Cell Death and Disease

4 April 2013

More than 33,000 childhood cancer survivors living in the UK

An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012. An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012.

14 November 2012

Smart drug improves survival in older patients with acute myeloid leukaemia

Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease, results from a major phase III Cancer Research UK-funded trial led by Cardiff University show today (Saturday). Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease, results from a major phase III Cancer Research UK-funded trial led by Cardiff University show today (Saturday).

10 November 2012

• Health & Medicine

Drug's 'double hit' overcomes leukaemia resistance

A drug that uses a unique ‘double hit’ to kill leukaemia cells could be a potential new treatment for patients with acute myeloid leukaemia. The research, majority funded by Cancer Research UK, is published this week in Leukaemia. A drug that uses a unique ‘double hit’ to kill leukaemia cells could be a potential new treatment for patients with acute myeloid leukaemia. The research, majority funded by Cancer Research UK, is published this week in Leukaemia.

12 July 2012

• Health & Medicine

Trial launched into testosterone replacement for male cancer survivors

Cancer Research UK is today launching a trial to see if male cancer survivors could benefit from hormone replacement therapy (HRT) with testosterone. Cancer Research UK is today launching a trial to see if male cancer survivors could benefit from hormone replacement therapy (HRT) with testosterone.

28 June 2012

• Health & Medicine

Cancer Research UK launches trial of new drug to treat acute childhood leukaemia

Cancer Research UK's Drug Development Office has opened the first trial of a new type of leukaemia drug. Cancer Research UK's Drug Development Office has opened the first trial of a new type of leukaemia drug.

27 January 2012

• Health & Medicine

More than five thousand children saved since 70s thanks to better cancer treatment

At least 5,600 more children have survived for at least five years after being diagnosed with cancer than would have done if survival rates had remained as they were in the early 1970s, according to new statistics from Cancer Research UK. At least 5,600 more children have survived for at least five years after being diagnosed with cancer than would have done if survival rates had remained as they were in the early 1970s, according to new statistics from Cancer Research UK.

14 November 2011

Scientists demonstrate potential new treatment for most common form of infant leukaemia

A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies, according to a study published in Nature today (Sunday). A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies, according to a study published in Nature today (Sunday).

2 October 2011